PubMed:33152450 / 236-402
Annnotations
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T4","span":{"begin":34,"end":42},"obj":"Disease"}],"attributes":[{"id":"A4","pred":"mondo_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Forty-one patients with confirmed COVID-19 were enrolled in the study and divided into two groups: artemisinin-piperaquine (AP) group (n=23) and control group (n=18)."}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T2","span":{"begin":124,"end":126},"obj":"http://purl.obolibrary.org/obo/CLO_0001547"},{"id":"T3","span":{"begin":160,"end":164},"obj":"http://purl.obolibrary.org/obo/CLO_0007919"},{"id":"T4","span":{"begin":160,"end":164},"obj":"http://purl.obolibrary.org/obo/CLO_0007920"}],"text":"Forty-one patients with confirmed COVID-19 were enrolled in the study and divided into two groups: artemisinin-piperaquine (AP) group (n=23) and control group (n=18)."}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T2","span":{"begin":99,"end":110},"obj":"Chemical"},{"id":"T3","span":{"begin":111,"end":122},"obj":"Chemical"},{"id":"T4","span":{"begin":124,"end":126},"obj":"Chemical"},{"id":"T7","span":{"begin":128,"end":133},"obj":"Chemical"},{"id":"T8","span":{"begin":153,"end":158},"obj":"Chemical"}],"attributes":[{"id":"A2","pred":"chebi_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CHEBI_223316"},{"id":"A3","pred":"chebi_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/CHEBI_91231"},{"id":"A4","pred":"chebi_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/CHEBI_28971"},{"id":"A5","pred":"chebi_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/CHEBI_73393"},{"id":"A6","pred":"chebi_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/CHEBI_81686"},{"id":"A7","pred":"chebi_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"},{"id":"A8","pred":"chebi_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"}],"text":"Forty-one patients with confirmed COVID-19 were enrolled in the study and divided into two groups: artemisinin-piperaquine (AP) group (n=23) and control group (n=18)."}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"21","span":{"begin":10,"end":18},"obj":"Species"},{"id":"22","span":{"begin":34,"end":42},"obj":"Disease"},{"id":"23","span":{"begin":99,"end":122},"obj":"Chemical"}],"attributes":[{"id":"A21","pred":"tao:has_database_id","subj":"21","obj":"Tax:9606"},{"id":"A22","pred":"tao:has_database_id","subj":"22","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Forty-one patients with confirmed COVID-19 were enrolled in the study and divided into two groups: artemisinin-piperaquine (AP) group (n=23) and control group (n=18)."}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T5","span":{"begin":0,"end":166},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Forty-one patients with confirmed COVID-19 were enrolled in the study and divided into two groups: artemisinin-piperaquine (AP) group (n=23) and control group (n=18)."}